Clinical bottom line
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), presents a significant challenge in pulmonology due to its impact on pulmonary function. Clinicians need to be aware of the potential for persistent respiratory symptoms and impaired lung function in patients recovering from COVID-19. Current evidence suggests that a multidisciplinary approach, including pulmonary rehabilitation and personalized management strategies, may be beneficial in addressing these long-term effects.
What the evidence shows
Recent studies have highlighted that a subset of patients recovering from COVID-19 continue to experience respiratory symptoms such as dyspnea, cough, and reduced exercise tolerance. A systematic review by Lopez-Leon et al. (2021) found that approximately 10-30% of COVID-19 survivors experience long-term respiratory symptoms [PMID: 33655256]. Another study by Huang et al. (2021) reported that 6 months post-infection, 63% of patients had persistent fatigue or muscle weakness, and 26% had sleep difficulties, with a significant proportion showing abnormal lung function [PMID: 33428822].
Pulmonary function tests (PFTs) in long COVID patients often reveal restrictive patterns, reduced diffusion capacity, and abnormalities in lung imaging. A study by Mo et al. (2020) indicated that 47% of patients had impaired diffusion capacity at 3 months post-discharge, highlighting the need for ongoing pulmonary assessment [PMID: 32729289].
Caveats and uncertainty
The heterogeneity of long COVID symptoms and their overlap with other post-viral syndromes complicate diagnosis and management. The pathophysiology of long COVID remains poorly understood, with hypotheses ranging from persistent viral reservoirs to immune dysregulation. The variability in study designs, patient populations, and follow-up durations further complicates the interpretation of findings.
Moreover, the long-term trajectory of pulmonary recovery in long COVID patients is still uncertain. While some patients show gradual improvement, others may experience persistent or even worsening symptoms. The lack of standardized diagnostic criteria and treatment protocols for long COVID adds to the uncertainty in clinical practice.
How this may change practice
Awareness of long COVID's impact on pulmonary function is crucial for pulmonologists. Early identification and management of respiratory symptoms can improve patient outcomes. Incorporating routine PFTs and imaging studies in the follow-up of COVID-19 survivors may help identify those at risk of long-term pulmonary impairment.
Multidisciplinary care, including pulmonary rehabilitation, may enhance recovery by improving exercise capacity and quality of life. Clinicians should also consider psychological support, as mental health issues are prevalent in long COVID patients. Personalized management plans that address both physical and psychological aspects are likely to be most effective.